Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen.
Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen. Research Abstract Details
Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen. Abstract Text:
Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen. Publishing Authors By Initials
Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen. Journal Published:
PUBLICATION TYPE: Letter
Journal: Journal of clinical oncology : official journal of
VOLUME: 26
Page Numbers: 3291; author reply 3291
Journal Abbreviation: J. Clin. Oncol.
ISSN: 1527-7755
DAY: 1
MONTH: Jul
YEAR: 2008
Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 8309333
Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen. Keywords Mesh Terms:
KEYWORDS:
MESH TERMS:
Chemical & Substance for Abstract: Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen. Information
Substance Name:
Registry Number:
Grant and Affiliation Information for Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen.
AFFILIATION:
Country: United States
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: J Clin Oncol
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen Related Publications